Analyst recommendations: Fedex, Merck, Nike, Coinbase, Tesla…

Biogen Inc.: BMO Capital Markets downgrades to market perform from outperform with a target price reduced from USD 230 to USD 164.
Evercore Inc.: Keefe Bruyette & Woods upgrades to outperform from market perform with a price target raised from USD 269 to USD 339.
Exelixis, Inc.: BMO Capital …
© MarketScreener.com 2024